TrialBritish journal of clinical pharmacology2026

Early clinical pharmacology evaluation of the novel anti-inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions.

Dave Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.